Keywords: alnylam, benitec, agree, deal, rnai, intellectual, property

Alnylam and Benitec agree deal on RNAi intellectual property

Article | 25 April 2005

Alnylam Pharmaceuticals, an RNAi therapeutics firm, and fellow US company Benitec, have entered into a licensing agreement over the reciprocal ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in